<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>World-wide, approximately 25% of <z:hpo ids='HP_0000001'>all</z:hpo> human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> are caused by infectious organisms, including approximately 10% of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> occurring in resource rich areas of the world </plain></SENT>
<SENT sid="1" pm="."><plain>While some of these disorders are more likely to be seen in patients with underlying <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo>, this is not a requisite for development of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, and most patients, in fact, are not immune-suppressed at the time of diagnosis </plain></SENT>
<SENT sid="2" pm="."><plain>In considering <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e>, several organisms have been implicated in disease etiology </plain></SENT>
<SENT sid="3" pm="."><plain>These organisms include Human Herpesvirus 8 (HHV8/KSHV), which is linked to primary effusion <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and to multicentric Castleman s disease, as well as to development of <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo>; Epstein Barr Virus (EBV) which has been associated with Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and nasal T cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, among others; Human T lymphotrophic virus type I (HTLV 1), which is associated with Adult T cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ATLL</z:e>); <z:hpo ids='HP_0012115'>Hepatitis</z:hpo> C virus, associated with splenic marginal and other <z:hpo ids='HP_0002665'>lymphomas</z:hpo>; and Helicobacter pylori, associated with gastric MALT <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The presentation will focus on the latter three disorders, describing pathogenesis of disease, clinical manifestations and therapeutic options </plain></SENT>
</text></document>